Fintel on MSN

D. Boral Capital Maintains Kairos Pharma (KAPA) Buy Recommendation

Fintel reports that on October 7, 2025, D. Boral Capital maintained coverage of Kairos Pharma (NYSEAM:KAPA) with a Buy recommendation. Analyst Price Forecast Suggests 585.48% Upside As of September 30 ...
Fintel on MSN

D. Boral Capital Maintains UroGen Pharma (URGN) Buy Recommendation

Fintel reports that on October 3, 2025, D. Boral Capital maintained coverage of UroGen Pharma (NasdaqGM:URGN) with a Buy ...
STAT

Why direct-to-consumer sales are unlikely to significantly lower drug costs

Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Among the demands that ...
Forbes

Optimizing R&D In Pharma: R&D Operations Ecosystem Powered By Cloud Computing

The pharmaceutical industry has immense pressure to deliver advanced and novel therapies to patients worldwide but faces monumental challenges in drug development. On average, the journey from ...
Forbes

$6.16 Billion Per Drug Approval: Almost Half of Big Pharma Companies Hit Negative R&D Productivity

Steven Paul’s “How to improve R&D productivity: the pharmaceutical industry's grand challenge” published in Nature Reviews Drug Discovery in 2010 is one of the highest cited and most frequently quoted ...